U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C6H14N2.C2O4.Pt
Molecular Weight 397.292
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXALIPLATIN

SMILES

[Pt++].[O-]C(=O)C([O-])=O.N[C@@H]1CCCC[C@H]1N

InChI

InChIKey=ZROHGHOFXNOHSO-BNTLRKBRSA-L
InChI=1S/C6H14N2.C2H2O4.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h5-6H,1-4,7-8H2;(H,3,4)(H,5,6);/q;;+2/p-2/t5-,6-;;/m1../s1

HIDE SMILES / InChI
Molecular Formula C2O4
Molecular Weight 88.019
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula Pt
Molecular Weight 195.084
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C6H14N2
Molecular Weight 114.1888
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:09:57 UTC 2023
Edited
by admin
on Sat Dec 16 17:09:57 UTC 2023
Record UNII
04ZR38536J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OXALIPLATIN
EP   INN   JAN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
USAN   INN  
Official Name English
OXALIPLATIN [JAN]
Common Name English
Oxaliplatin [WHO-DD]
Common Name English
OXALIPLATIN [MART.]
Common Name English
OXALIPLATIN [USP MONOGRAPH]
Common Name English
PLATINUM, ((1R,2R)-1,2-CYCLOHEXANEDIAMINE-.KAPPA.N,.KAPPA.N')(ETHANEDIOATO(2-)-.KAPPA.O1,.KAPPA.O2)-, (SP-4-2)-
Common Name English
JM-83
Code English
Xelox component oxaliplatin
Common Name English
Folfox component oxaliplatin
Common Name English
OXALIPLATIN [VANDF]
Common Name English
OXALIPLATIN [ORANGE BOOK]
Common Name English
OXALIPLATIN [EP MONOGRAPH]
Common Name English
SR-96669
Code English
oxaliplatin [INN]
Common Name English
MBP-426 (LIPOSOMAL OXALIPLATIN)
Code English
NSC-266046
Code English
OXALIPLATIN [USP-RS]
Common Name English
OXALIPLATIN [EP IMPURITY]
Common Name English
XALIPLATIN
Brand Name English
(SP-4-2-(1R-TRANS))-(1,2-CYCLOHEXANEDIAMINE-N,N')(ETHANEDIOATO(2-)-O,O')PLATINUM
Common Name English
OXALIPLATIN [MI]
Common Name English
ELOXATIN
Brand Name English
OXALIPLATIN [USAN]
Common Name English
L-OHP
Code English
RP-54780
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 561716
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
WHO-VATC QL01XA03
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
WHO-ATC L01XA03
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
FDA ORPHAN DRUG 560816
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
FDA ORPHAN DRUG 605617
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
LIVERTOX NBK548456
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
NCI_THESAURUS C1450
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
NDF-RT N0000175073
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
NDF-RT N0000175413
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
FDA ORPHAN DRUG 69492
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
Code System Code Type Description
INN
6012
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
MESH
C030110
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
DRUG BANK
DB00526
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
CHEBI
31941
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
FDA UNII
04ZR38536J
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
IUPHAR
7433
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
DRUG CENTRAL
4210
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
RS_ITEM_NUM
1481204
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
CAS
61825-94-3
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
MERCK INDEX
m8281
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY Merck Index
EPA CompTox
DTXSID0036760
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
DAILYMED
04ZR38536J
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
SMS_ID
100000085171
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
EVMPD
SUB09490MIG
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
NSC
266046
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
RXCUI
32592
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY RxNorm
LACTMED
Oxaliplatin
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
ChEMBL
CHEMBL414804
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
WIKIPEDIA
OXALIPLATIN
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
NCI_THESAURUS
C1181
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
USAN
KK-45
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
PUBCHEM
9887054
Created by admin on Sat Dec 16 17:09:57 UTC 2023 , Edited by admin on Sat Dec 16 17:09:57 UTC 2023
PRIMARY
Related Record Type Details
Structure of OXALIPLATIN, C14-
LABELED -> NON-LABELED
Structure of OXALIPLATIN
BASIS OF STRENGTH->SUBSTANCE
ASSAY (HPLC)
EP
OCT-2
TRANSPORTER -> SUBSTRATE
MAY BE RESPONSIBLE FOR THE ACTIVITY OF OXALIPLATIN AGAINST against colorectal tumors
MAJOR
Structure of OXALIPLATIN
BASIS OF STRENGTH->SUBSTANCE
ASSAY (HPLC)
USP
OCT-1
TRANSPORTER -> SUBSTRATE
MAY BE RESPONSIBLE FOR THE ACTIVITY OF OXALIPLATIN AGAINST against colorectal tumors
MAJOR
Related Record Type Details
Structure of OXALIC ACID
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of DIAQUODIAMINOCYCLOHEXANEPLATINUM DINITRATE, (R,R)-
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of OXALIPLATIN, (S,S)-
IMPURITY -> PARENT
limites not given
EP
Structure of (1,2-CYCLOHEXANEDIAMINE-N,N') DIIODIDOPLATINUM(II), (SP-4-2-(1R-TRANS))-
IMPURITY -> PARENT
Structure of (R,R-1,2-DIAMINOCYCLOHEXANE)DINITRATOPLATINUM
IMPURITY -> PARENT
Structure of DIHYDROXY OXALIPLATIN-PT(IV)
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of DIAQUODIAMINOCYCLOHEXANEPLATINUM DINITRATE, (R,R)-
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of DIHYDROXY OXALIPLATIN-PT(IV)
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of (SP-4-2)-Dichloro[(1R,2R)-1,2-cyclohexanediamine-κN<SUP>1</SUP>,κN<sup>2</sup>]platinum
IMPURITY -> PARENT
Structure of OXALIPLATIN, (S,S)-
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of OXALIC ACID
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
Structure of OXALIPLATIN
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966